Introduction Opioid use disorder (OUD) is a debilitating illness that remains a serious public
health issue in the United States. Use of telemedicine to deliver m edications for the …

Objective The COVID-19 pandemic has transformed care delivery for patients with opioid
use disorder (OUD); however, little is known about the experiences of front-line clinicians in …

Background Changes in federal policy during the COVID-19 pandemic allowing for the use
of telemedicine to treat opioid use disorder (OUD) have facilitated innovative strategies to …

The coronavirus disease pandemic of 2019 (COVID-19) has created significant economic
and societal burden, with mortality currently exceeding 615,000 and millions of others …

Background: The drug-related overdose crisis worsened during the COVID-19 pandemic.
Recent drug policy changes to increase access to medications for opioid use disorder …

Methods Five health systems with MOUD programs completed questionnaires regarding
their tele-MOUD models and provided aggregated sociodemographic data for MOUD …

Background The majority of individuals with opioid use disorder (OUD) face access barriers
to evidence-based treatment, and the COVID-19 pandemic has exacerbated the United …

Background This study investigated the efficacy and safety of providing medication for opioid
use disorder (MOUD) and individualized telehealth in Kentucky, a state severely impacted …

Objective To understand clinician use of and opinions about telemedicine for opioid use
disorder (tele-OUD) during the COVID-19 pandemic. Methods An electronic national survey …

Background To determine how clinicians with a DATA waiver to prescribe buprenorphine for
opioid use disorder (OUD) adapted during the COVID-19 pandemic to emergency …